Past attendees of our annual forum include:

3i Group

Abingworth Management Limited

ABN AMRO

Acceptys

AIG Private Bank

Akzo Nobel

Alloferon

Alta Vista Corporate Finance Beratung GmbH

A-M Pharma B.V.

Amsterdam Molecular Therapeutics

Angewandte Biologische Chemie

AP Asset Management

Apax Partners & Co.

Aravis Venture Associates

Association Alsace BioValley

Association of the Chemical Industry (VCI)

ATAG Ernst & Young

Audit Institute for Medical Services and Quality Assurance GmbH

Aventis Pharma AG

Aventis R & T GmbH & Co KG

Axonyx, Inc.

Baden-Wuerttembergische Bank AG

Bank Gesellschaft Berlin

Bank Sal Oppenheim Jr. & Cie

Bank Vontobel AG

BankInvest

BASF-LYNX Bioscience AG

Bayer Innovation Fund

BBB Biomedieinsche Forschungs

BD Ventures

BdW Asset management

Bellevue Asset Management

Bfactory

Biogen

Bio-Gen-Tec-NRW

Biomedicine Management Partners

BioMentor B.V.

BioPartner

Biopharmaceutical Communications Consulting

Bioscience Management Consulting

BioSciFi Advisors LLC

Biosearch Italia

Biosphere

Biotech-Healthcare Partners, Inc.

BioTechnology Industry Organization (BIO)

Biotechnology Investment Today (BIT)

BiotechWatch.com

BioTecnol

BioVeda Capital

BioVenture

BioWorld Online/BioWorld Today

Blau Mancino Associates

Bloomberg L.P.

Bmp Life Science AG Venture Capital

Boehringer Ingelheim GmbH

Bopp Company

Boston Life Science, Inc

Breslin Biotech-Dresdner Bank

Bristol-Myers Squibb

Bundesarbeitsgemeinschaft Gentechnik und Recht

BYK Gulden

Cambridge Pharma Consultancy Ltd.

CAT Finance

Center for Proteome Analysis

Centuria Science & Technology Park

Close Brothers

Commerzbank Asset Management

CoreValve SA

Cortical Studios

CR Bard 

Creatogen AG

CryptoGen

De Telegraph

Degussa-Huels AG

Delco Advisors

Der Regierungspraesident, Darmstadt

Deutsche Bank AG

Deutscher Investment Trust

Devax, Inc.

DG Bank

Die Telebörse

Dong-A Pharm.Co.,Ltd.

Dow Jones Newswires

D-Pharm

Dresdner Bank AG

Dresdner Bank AG

Dresdner Kleinwort Benson

Dresdner Kleinwort Capital

Dresdner Kleinwort Wasserstein

Drug Discovery Ltd

DVFA

DZ Bank AG

Eastman Chemical

Elan Corporation, PLC.

Euronext N.V.

Federated Kaufmann Fund

FEI Capital 

Fischer & Limberger

Fortis Bank

Frankfurt Economic Development GmbH

Frankfurter Allgemeine Zeitung GmbH

Fraunhofer Management GmbH

Fresenius HemoCare GmbH

Future Capital AG

G.I.T Verlag GmbH

GAEDERTZ Rechtsanwalte

GDS

Gene Networks

Genius GmbH

Genodyssee

Genzyme Europe

GFI Servizi Finanziari SA

GIMV

Global Biomedical Partners

Global Health Care Partners

Goedecke

Going Public Media AG

Graffinity Pharmaceutical Design

Grunenthal GmbH

Guidant

Haarmann Hemmelrath & Partners

Heidelberg Innovation Fund

Hessian Ministry of Economics

HTS GmbH

IBM Deutschland Imformationssystems GmbH

Ice Securities Limited

Index Securities

Industrial Investment Council

Industrie und Handelskammer

Infraserv GmbH & Co. Hoechst KG

Innotact Consulting

INSEAD

International Biomedicine Management Partners

Investigen

Inovation Ventures LLC

InvestitionsBank Hessen AG

ITX Corporation

Japan Lifeline Co., Ltd

Johnson & Johnson Depuy

K.U.N. Dept of Molecular and Laser Physics

Knoll AG

Kowa Research Europe Ltd.

Lehman Brother, Inc.

LG Chem Investment, Ltd

Liberal Party

Life Science Consultants

Life Science Partners

Lombard Odier

Lommaert & Blondeel Consultants Ltd

Macrozyme B.V.

Malcolm Consulting

Managing Resources

Mancino Burfield Edgerton

Marubeni America Corporation

Marubeni Corporation

Marx Financial Group

MBG Hessen GmbH

Mediabiotech SA

Medicis Aktiengesellschaft

Mediport VC Management GmbH

Medizinische Klinik und Poliklinik B

Westfaelische Wilhelms-Universitaet

Menarini s.p.a.

Merck Biopharmaceuticals

Merck KGaA

Merck Lipha 

Merlin Biosciences

Merska

Merz + Co. GmbH & Co.

Merz Pharma

M-phasys GmbH

MPM Asset Management LLC

MPM Capital 

Mundipharma International Ltd.

Nauta Dutilh N.V.

NIB Capital

NicOx

Nikkei Business Publications

Nikko Synergy Partners

NMT Management AG

NMT Ventures

Nomura Bank

Nordic Biotech 

Novuspharma

Nuevolution 

Octoplus

Osaka Prefecture

OXO Chemie AG

P.C. Frey & Partner, AG

Pacific Corporation 

Pacific Pharmaceutical

Pathofinder B.V.

Paul Capital

PBS Bank

Pheonix International Switzerland AG

Philips Medical Systems

Pictet & Cie

Pillsbury Winthrop

Plenum Finanz AG

PMM Management Consultants GmbH

Polimun Scientific

Polytechnos Venture Partners

Post Genome Institute Co., Ltd

Protein Labelling Innovation

Proxy Laboratories B.V.

R&S Investments AG

Rabo Securities NV

Reabourne Technology Investment Management

Redaktorin

Reqmed Company

Revotar Biopharmaceuticals AG 

Rohe & Wuest GmbH

Russell Reynolds Associates

Schiff Hardin & Waite

Science4Life

Seed Karlsruhe GmbH

SG Cowen & Co.

SG Ruegg Bank AG

Shire Pharmaceuticals

Sidley Austin Brown & Wood LLP 

Sigma Tau Pharmaceuticals

Sina-Maassen

SODEVAL SA

Strategic Health Innovations 

Sued Venture Capital GmbH

Swiss Partners Investment Network

Swiss Value Management

Target Biomedical Research and Consulting Company Ltd.

Technologieholding

TechnoStart Beratungsgeselischaft

Fur Beteiligungsfonds mbH

TEDA

Terumo Europe

The Trout Group LLC

Three Crown Capital

toBBB

Townsend, Townsend & Crew

Toyota Tsusho

TVM Techno Venture Management 

UBS Asset Manager

UCL Ventures

Union Investment

United European Bank

University of Tokyo

University of Zurich

Van Daalen & Cie.

VenGen

Vereinigte Wirtschaftsdienste GmbH

Vertical*l SA 

Virimmune

Weiss Associates

Weiss Peck & Greer Life Science Fund

Windhover Publications

Wirtschaftsfoerderung Frankfurt GmbH

Wolfson Institute for Biomedical Research

Z-Cube

Zambon Group SpA

Zernike Group

Zimmer & Associates AG